ISIS Pharmaceuticals (ISIS)

Add to Watchlists
Create an Alert
67.32 +0.61  +0.91% NASDAQ May 29, 8:00PM Delayed 2m USD
View Full Chart
ISIS Price Chart
View All Events

ISIS Events

Date Type Description
05/18/2015 Misc 2014 Interactive Annual Report
05/05/2015 11:30 EDT Misc ISIS Pharmaceuticals Inc First Quarter Earnings Conference Call in 2015
05/05/2015 Earnings ISIS Pharmaceuticals Inc First Quarter Earnings in 2015 Release
02/27/2015 10:30 EDT Misc ISIS Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
02/27/2015 Earnings ISIS Pharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
11/07/2014 08:30 PST Misc Q3 2014 Isis Pharmaceuticals Earnings Conference Call
11/07/2014 Earnings Q3 2014 Isis Pharmaceuticals Earnings Results
08/04/2014 10:30 EDT Misc Q2 2014 Isis Pharmaceuticals Earnings Conferecec Call
08/04/2014 Earnings Q2 2014 Isis Pharmaceuticals Earnings Results
View All Performance Charts

ISIS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ISIS Pharmaceuticals is up 118.7% over the last year vs S&P 500 Total Return up 12.63%, Biogen up 24.12%, and ANI Pharmaceuticals up 53.79%.

PDF Report for ISIS

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ISIS Pro Report PDF
Advertisement

ISIS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.isispharm.com
  • IR Website: http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Isis Pharmaceuticals Inc is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.

ISIS Excel Add-In Codes

  • Name: =YCI("ISIS","name")
  • Description: =YCI("ISIS","description")
  • Sector: =YCI("ISIS","sector")
  • Industry: =YCI("ISIS","industry")
  • Est. Current Fiscal Year End: =YCI("ISIS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.